EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer

Haixia He, Qianghua Zhou, Yangjie Zhang, Yi Li, Lin Ding, Ting Shen, Sen Liu, Shengmeng Peng, Ming Huang, Hua Zhou, Liang Cheng, Ruihui Xie und 7 weitere

Advanced Science · 2024-11 · 11 (42)

DOI: 10.1002/advs.202405997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.09.2024. Verfasst von Haixia He und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. Hauptthemen laut MEDLINE: Polypyrimidine Tract-Binding Protein, Heterogeneous-Nuclear Ribonucleoproteins, Prostatic Neoplasms, Radiation Tolerance. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Guangzhou, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy is a curative arsenal for prostate cancer (PCa), but radioresistance seriously compromises its effectiveness. Dysregulated RNA splicing factors are extensively involved in tumor progression. Nonetheless, the role of splicing factors in radioresistance remains largely unexplored in PCa. Here, 23 splicing factors that are differentially expressed between PCa and adjacent normal tissues across multiple public PCa databases are identified. Among those genes, polypyrimidine tract binding protein 1 (PTBP1) is significantly upregulated in PCa and is positively associated with advanced clinicopathological features and poor prognosis. Gain‐ and loss‐of‐function experiments demonstrate that PTBP1 markedly reinforces genomic DNA stability to desensitize PCa cells to irradiation in vitro and in vivo. Mechanistically, PTBP1 interacts with the heterogeneous nuclear ribonucleoproteins (hnRNP) associated with lethal yellow protein homolog (RALY) and regulates exon 5 splicing of DNA methyltransferase 3b (DNMT3B) from DNMT3B‐S to DNMT3B‐L. Furthermore, upregulation of DNMT3B‐L induces promoter methylation of dual‐specificity phosphatase‐2 (DUSP2) and subsequently inhibits DUSP2 expression, thereby increasing radioresistance in PCa. The findings highlight the role of splicing factors in inducing aberrant splicing events in response to radiotherapy and the potential role of PTBP1 and DNMT3B‐L in reversing radioresistance in PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polypyrimidine Tract-Binding ProteinHeterogeneous-Nuclear RibonucleoproteinsProstatic NeoplasmsRadiation ToleranceDNA Methyltransferase 3BAlternative SplicingDNA (Cytosine-5-)-MethyltransferasesMaleHumansMiceAnimalsCell Line, TumorGene Expression Regulation, NeoplasticDisease Models, Animal

Stichwörter der Autor:innen

DNMT3BPTBP1prostate cancerradioresistancesplicing factor

Substanzen

Polypyrimidine Tract-Binding ProteinHeterogeneous-Nuclear RibonucleoproteinsPTBP1 protein, humanDNA Methyltransferase 3BDNA (Cytosine-5-)-Methyltransferases

Autor:innen und Institutionen

  • Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
  • Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
  • Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Department of Urology, Pu'er People's Hospital of Yunnan Province, Pu'er, 665000, China.

ORCID-Profile: Xu Chen

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Program of Guangzhou
  • China Postdoctoral Science Foundation
  • Guangdong Provincial Clinical Research Centre for Urological Diseases
  • Natural Science Foundation of Guangdong Province
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

He, H., Zhou, Q., Zhang, Y., Li, Y., Ding, L., Shen, T., Liu, S., Peng, S., Huang, M., Zhou, H., Cheng, L., Xie, R., Zhang, Q., Lu, J., Li, L., Yang, J., Bai, S., Lin, T., & Chen, X. (2024). PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer. Advanced Science, 11(42). https://doi.org/10.1002/advs.202405997

Vancouver

He H, Zhou Q, Zhang Y, Li Y, Ding L, Shen T, et al. PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer. Advanced Science. 2024;11(42). doi:10.1002/advs.202405997

BibTeX
@article{He2024,
  author = {He, Haixia and Zhou, Qianghua and Zhang, Yangjie and Li, Yi and Ding, Lin and Shen, Ting and Liu, Sen and Peng, Shengmeng and Huang, Ming and Zhou, Hua and Cheng, Liang and Xie, Ruihui and Zhang, Qiang and Lu, Junlin and Li, Liting and Yang, Jing and Bai, Shoumin and Lin, Tianxin and Chen, Xu},
  title = {PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {42},
  doi = {10.1002/advs.202405997}
}
Kostenlos starten →